Company Filing History:
Years Active: 2011
Title: Greta G Cary: Innovator in Nanoparticulate Compositions
Introduction
Greta G Cary is a notable inventor based in Landsdale, PA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of nanoparticulate compositions.
Latest Patents
Greta holds a patent for "Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors." This invention describes nanoparticulate compositions that comprise at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer. The compositions have an average particle size of less than about 2000 nm. Additionally, the patent outlines methods for making and using these compositions.
Career Highlights
Greta is currently associated with Elan Pharma International Limited, where she applies her expertise in developing innovative pharmaceutical solutions. Her work focuses on enhancing the solubility and bioavailability of therapeutic agents.
Collaborations
Greta has collaborated with esteemed colleagues, including H William Bosch and Douglas C Hovey, to advance her research and development efforts.
Conclusion
Greta G Cary's contributions to nanoparticulate compositions highlight her innovative spirit and dedication to improving pharmaceutical formulations. Her work continues to impact the field positively.